Oral Covid vaccine maker's stock tumbles on poor trial results
February 03, 2021 at 11:08 AM EST
The vaccine did not show signs that patients generated antibodies specific to the Covid-causing virus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|